On May 13, 2026, China’s Ministry of Industry and Information Technology (MIIT) and three other departments jointly issued the national standard Technical Requirements for Artificial Intelligence Terminal Intelligence Grading (GB/T 45287–2026). This is the first national standard to mandate intelligence grading for medical imaging devices, surgical navigation systems, AGV scheduling terminals, and IoT-enabled temperature-controlled warehouse terminals—signaling direct regulatory implications for manufacturers and exporters serving healthcare, smart logistics, and cross-border medical device markets.
On May 13, 2026, the Ministry of Industry and Information Technology, the State Administration for Market Regulation, the National Medical Products Administration, and the National Health Commission jointly released GB/T 45287–2026. The standard defines five intelligence levels (L1–L5) for AI-powered terminals and explicitly includes medical imaging equipment, surgical navigation systems, AGV scheduling terminals, and IoT-based temperature-controlled warehouse terminals in its mandatory grading scope. It stipulates that products rated L3 or higher must pass verification of local edge inference capability and multimodal interaction performance. The standard also notes its relevance to market access pathways under the EU Medical Device Regulation (MDR), U.S. FDA 510(k) clearance, and emerging regulatory frameworks in Southeast Asia.
These enterprises are directly subject to the new grading requirements when deploying AI features in imaging systems or surgical navigation platforms. Impact manifests in product certification timelines, design validation protocols (especially for on-device inference), and documentation needed for parallel regulatory submissions in overseas markets.
Firms producing AGV control terminals or IoT-enabled cold-chain warehouse management systems must now align functional architecture with L3+ verification criteria—including real-time decision-making at the edge and interoperability across voice, visual, and sensor modalities. This affects firmware development cycles and third-party testing engagement.
Organizations supporting clients in EU MDR, FDA 510(k), or ASEAN market entry now need to incorporate GB/T 45287–2026 grading evidence into technical files and conformity assessments. The standard does not replace existing regulatory requirements but introduces an additional layer of technical benchmarking relevant to AI functionality claims.
The standard is published as GB/T (recommended national standard), not GB (mandatory). However, its reference in MDR/FDA/ASEAN context signals de facto influence. Stakeholders should monitor announcements from MIIT or SAMR on pilot enforcement, interpretation documents, or alignment plans with international standards bodies.
Manufacturers should audit current portfolios against the four explicitly named terminal types: medical imaging devices, surgical navigation systems, AGV scheduling terminals, and IoT temperature-controlled warehouse terminals. Products meeting the functional definition—even if branded differently—may fall within scope and require grading preparation.
While GB/T 45287–2026 sets technical benchmarks, it does not yet prescribe penalties or phase-in deadlines. Analysis shows this is currently a framework-setting measure—not an immediate compliance mandate. Enterprises should treat it as a forward-looking design and documentation guide rather than an urgent certification trigger.
Teams responsible for hardware-software co-design, AI model deployment, and regulatory affairs should jointly review how local edge inference and multimodal interaction will be verified. This includes defining test scenarios, selecting accredited labs, and documenting inference latency, accuracy under offline conditions, and modality handoff fidelity.
Observably, GB/T 45287–2026 functions primarily as a signaling mechanism—not an enforcement instrument—at this stage. Its inclusion of specific terminal types and explicit linkage to international regulatory pathways suggests China is institutionalizing AI capability evaluation as part of broader digital infrastructure governance. From an industry perspective, this standard better reflects a coordination effort across domestic industrial policy and global market access strategy than a standalone technical regulation. It is more accurately understood as a preparatory milestone: one that anticipates future convergence between China’s AI grading framework and internationally recognized AI assurance practices—particularly where safety-critical operation is involved.
Current attention should focus less on immediate compliance and more on understanding how intelligence grading may shape technical file expectations, lab testing demand, and interoperability assumptions in multi-jurisdictional deployments.
Conclusion
GB/T 45287–2026 marks the formal introduction of AI intelligence grading into China’s national standard system—with targeted applicability to high-impact terminals in healthcare and intelligent warehousing. Its significance lies not in immediate enforceability, but in establishing a shared technical reference point across domestic industry and international regulatory interfaces. For stakeholders, it is best understood today as an early-phase orientation tool: clarifying what capabilities will likely become material to market access, certification, and product lifecycle planning in the medium term—rather than as a binding operational requirement.
Source Attribution
Main source: Official announcement by MIIT, SAMR, NMPA, and NHC dated May 13, 2026; Standard GB/T 45287–2026 published by SAC (Standardization Administration of China).
Points requiring ongoing observation: Formal implementation guidelines, alignment status with IEC/ISO AI standards (e.g., ISO/IEC 23053), and any subsequent designation of GB/T 45287–2026 as a referenced standard in mandatory regulatory notices.
Related News
Get weekly intelligence in your inbox.
No noise. No sponsored content. Pure intelligence.